New Hampshire Clinical Trials
Browse actively recruiting clinical trials with research sites in New Hampshire. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in New Hampshire
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)Lebanon, NH
- Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and RadiationNCT07615049PHASE3SWOG Cancer Research NetworkRecurrent Soft Tissue Sarcoma of the Trunk and ExtremitiesLebanon, NH
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyNCT05774951PHASE3AstraZenecaBreast Cancer, Early Breast CancerLaconia, NH
- A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)NCT06124157PHASE2National Cancer Institute (NCI)B Acute Lymphoblastic LeukemiaLebanon, NH
- Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)NCT06672146PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaLebanon, NH
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerNCT07195734PHASE2National Cancer Institute (NCI)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Lebanon, NH
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic AtrophyNCT06541704PHASE3Regeneron PharmaceuticalsAge-related Macular Degeneration (AMD)Nashua, NH
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerNCT03606967PHASE2National Cancer Institute (NCI)Anatomic Stage IV Breast Cancer AJCC v8Lebanon, NH
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNCT05136196PHASE2National Cancer Institute (NCI)Clinical Stage III Cutaneous Melanoma AJCC v8Lebanon, NH
- A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)NCT04302025PHASE2Genentech, Inc.Non-small Cell Lung CancerLebanon, NH
- Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)NCT07116967PHASE3Bristol-Myers SquibbPlaque PsoriasisPortsmouth, NH
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109PHASE3Alnylam PharmaceuticalsHigh Risk Cardiovascular DiseasePortsmouth, NH
Popular conditions in New Hampshire
Frequently asked questions
- How do I find clinical trials in New Hampshire?
- Corterve aggregates actively recruiting clinical trials with sites in New Hampshire from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in New Hampshire free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in New Hampshire?
- New Hampshire research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.